Dunn and colleagues have analyzed global gene expression in normal prostate epithelium and cancerous acini, and discovered unexpectedly consistent overexpression of myosin VI mRNA in clinical ...

JUPITER, Fla., Feb. 26, 2025 /PRNewswire/ -- Myosin Therapeutics, Inc., a biotechnology company developing novel therapies for cancer and neurological disorders, has closed its second seed funding ...